cbdMD, Inc.
Price Action
Technical Summary
EMERGING TRENDcbdMD, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Earnings growth of 84% provides fundamental context to the price action. Investors should exercise caution due to high volatility (156% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.85 | -2.39% | BELOW |
| 50 SMA | $0.79 | +5.29% | ABOVE |
| 100 SMA | $0.93 | -11.01% | BELOW |
| 150 SMA | $0.91 | -8.92% | BELOW |
| 200 SMA | $0.88 | -5.94% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is YCBD in an uptrend right now?
YCBD has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is YCBD overbought or oversold?
YCBD's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is YCBD outperforming the market?
YCBD has a Relative Strength (RS) Rating of 33 out of 99. YCBD is currently lagging the broader market.
Where is YCBD in its 52-week range?
YCBD is trading at $0.83, which is 32% of its 52-week high ($2.56) and 17% above its 52-week low ($0.47).
How volatile is YCBD?
YCBD has a Beta of 0.66 and 52-week volatility of 156%. It's less volatile than the S&P 500 - generally more stable.